JE
James Edgemond (CFO AND TREASURER) filed 33 Form 4 reports in the trailing twelve months (0 purchases, 33 sales), most often in United Therapeutics Corporation (UTHR). The largest single filing was $10.0M of UTHR (20,840 sh across 6 lots, as filed), executed Dec 1 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
33
0 buys · 33 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$170.2M
shares × price, as filed
Last traded
Jun 22
Filed Jun 23
Median ADV $265.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $216.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
33 filings
Sector per market data · by filing · past 12 months
Most traded names
UTHRRecent filings
UTHRSALE
United Therapeutics Corporation
View filing →
$5.6M9,840 sh across 13 lots
Exec May 26
Filed May 27 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $5.6M
9,960 sh across 6 lots
Exec May 21
Filed May 22 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $5.7M
9,960 sh across 7 lots
Exec May 18
Filed May 19 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $5.6M
9,760 sh across 7 lots
Exec May 14
Filed May 15 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $5.6M
9,831 sh across 10 lots
Exec May 11
Filed May 12 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $5.6M
9,720 sh across 16 lots
Exec May 7
Filed May 11 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $5.6M
9,647 sh across 9 lots
Exec May 4
Filed May 5 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $5.7M
9,960 sh across 10 lots
Exec Apr 30
Filed May 1 · 5:30 PM ET More filings →